The short version of Angiotensin IV fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-04. Anything still debated is marked as such rather than presented as settled.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
In 1972, a Honeywell 316 was displayed with a semiconductor RAM memory board (they used core memory previously). It was never placed into production, as DTL was too power-hungry to survive much longer. Honeywell knew that the same technology that enabled the production of RAM spelled the end of DTL computers, and wanted to show that the company was cutting edge.
== Delivery == In 2015, Jain et al. described a trans-acting DNA-based amphiphatic delivery system for convenient delivery of poly A tailed uncharged nucleic acids (UNA) such as PNAs and morpholinos, so that several UNA's can be easily screened ex vivo.
== History == The first monoamine oxidase inhibitor (MAOI), iproniazid, was discovered accidentally when developing the new antitubercular drug isoniazid. The drug was found to induce euphoria and improve the patient's appetite and sleep quality. The first tricyclic antidepressant, imipramine, was originally developed and studied to be an antihistamine alongside other first-generation antihistamines of the time, such as promethazine. TCAs can increase the level of norepinephrine and serotonin by inhibiting their reuptake transport proteins. The majority of TCAs exert greater effect on norepinephrine, which leads to side effects like drowsiness and memory loss. In order to be more effective on serotonin agonism and avoid anticholinergic and antihistaminergic side effects, selective serotonin reuptake inhibitors (SSRI) were researched and introduced to treat anxiety disorders. The first SSRI, fluoxetine (Prozac), was discovered in 1974 and approved by FDA in 1987. After that, other SSRIs like sertraline (Zoloft), paroxetine (Paxil), and escitalopram (Lexapro) have entered the market. The first serotonin norepinephrine reuptake inhibitor (SNRI), venlafaxine (Effexor), entered the market in 1993. SNRIs can target serotonin and norepinephrine transporters while avoiding imposing significant effects on other adrenergic (α1, α2, and β), histamine (H1), muscarinic, dopamine, or postsynaptic serotonin receptors.
== Microbiology == Daptomycin is bactericidal against Gram-positive bacteria only. It has proven in vitro activity against enterococci (including glycopeptide-resistant enterococci (GRE)), staphylococci (including methicillin-resistant Staphylococcus aureus), streptococci, corynebacteria and stationary-phase Borrelia burgdorferi persisters. Daptomycin's bactericidal activity is concentration-dependent and is preserved against organisms in the stationary phase of growth, distinguishing it from many antibacterials that depend on active cell division for lethal effect. In in vitro studies, the drug also produces a prolonged concentration-dependent post-antibiotic effect, during which bacterial growth remains suppressed after drug exposure ends. Membrane insertion and the resulting disruption of bacterial membrane integrity require the presence of both calcium ions and phosphatidylglycerol for membrane insertion.
Sources: en.wikipedia.org
==== Border walls ==== Border walls are a common aspect of border security measures worldwide. Border walls generally seek to limit unauthorised travel across an international border and are frequently implemented as a populist response to refugees and economic migrants. The India-Bangladesh barrier is a 3,406 kilometres (2,116 miles) long fence of barbed wire and concrete just under 3 metres (9 feet 10 inches) high, currently under construction. Its stated aim is to limit unauthorised migration. The project has run into several delays; there is no clear completion date for the project yet. Similar to India's barrier with Bangladesh and the proposed wall between America and Mexico, Iran has constructed a wall on its frontier with Pakistan. The wall aims to reduce unauthorised border crossings and stem the flow of drugs, and is also a response to terrorist attacks, notably the one in the Iranian border town of Zahedan on 17 February 2007, which killed thirteen people, including nine Iranian Revolutionary Guard officials. President Donald Trump's proposal to build a new wall along the border formed a major feature of his 2016 presidential campaign and over the course of his presidency, his administration spent approximately US$15 billion on the project, with US$5 billion appropriated from US Customs and Border Protection, US$6.3 billion appropriated from anti-narcotics initiative funded by congress and US$3.6 billion appropriated from the American military.
osmotic shock Also osmotic stress. Physiological dysfunction caused by a sudden change in the concentration of dissolved solutes in the extracellular environment surrounding a cell, which provokes the rapid movement of water across the cell membrane by osmosis, either into or out of the cell. In a severely hypertonic environment, where extracellular solute concentrations are extremely high, osmotic pressure may force large quantities of water to move out of the cell (plasmolysis), leading to its desiccation; this may also have the effect of inhibiting transport of solutes into the cell, thus denying it the substrates necessary to sustain normal cellular activities. In a severely hypotonic environment, where extracellular solute concentrations are much lower than intracellular concentrations, water is forced to move into the cell (turgescence), causing it to swell in size and potentially burst, or triggering apoptosis.
=== Mercuration of aromatic rings === Electron-rich arenes, such as phenol, undergo mercuration upon treatment with Hg(O2CCH3)2. The one acetate group that remains on the mercury atom can be displaced by chloride:
Russian media reported an attack by Ukrainian drones on the Afipsky oil refinery in Krasnodar Krai, as well as in oil depots in Tambov Oblast and Enem, Adygea. Authorities also claimed that drones were shot down over Bryansk, Rostov, Belgorod and Oryol Oblasts. One person was killed in a drone strike in Slavyansk-on-Kuban. Russia withdrew 80% of its soldiers from the Finnish border and redeployed them to Ukraine, according to an investigation by Finnish media. The Romanian government pledged to deliver a Patriot battery to Ukraine in exchange for a replacement unit from the US. John Kirby, National Security Council Coordinator for Strategic Communications, confirmed that the US government was to “reprioritise” all foreign exports of Patriot and NASAMS missiles in favour of Ukraine. Russia claimed that it used for the first time, a FAB-3000 modified with a guidance wing kit near Lyptsi, Kharkiv Oblast.
Relative bioavailability is one of the measures used to assess bioequivalence (BE) between two drug products. For FDA approval, a generic manufacturer must demonstrate that the 90% confidence interval for the ratio of the mean responses (usually of AUC and the maximum concentration, Cmax) of its product to that of the "brand name drug" is within the limits of 80% to 125%. Where AUC refers to the concentration of the drug in the blood over time t = 0 to t = ∞, Cmax refers to the maximum concentration of the drug in the blood. When Tmax is given, it refers to the time it takes for a drug to reach Cmax. While the mechanisms by which a formulation affects bioavailability and bioequivalence have been extensively studied in drugs, formulation factors that influence bioavailability and bioequivalence in nutritional supplements are largely unknown. As a result, in nutritional sciences, relative bioavailability or bioequivalence is the most common measure of bioavailability, comparing the bioavailability of one formulation of the same dietary ingredient to another.
Sources: en.wikipedia.org
== Personal life == Tiu Laurel was married to Francesca Carla Winebrenner, an actress known by the stage name Cheska Iñigo and a member of the board of director of Winebrenner & Iñigo Insurance Brokers, Inc. He is currently partnered with Yana, a Ukrainian. He has three children. His daughter Kei is a managing director of Frabelle Group and is married with two children as of 2018, making him a grandfather. His son Miko was an equestrian for Sarah Lawrence College during its 2014–15 campaign.
Tofu has also been fused into other cuisines in the West, for instance in Indian-style curries. Tofu and soy protein can be industrially processed to match the textures and flavors of cheese, pudding, eggs, bacon, and similar products. Tofu's texture can also be altered by freezing, puréeing, and cooking. In the Americas, Europe, Australia and New Zealand, tofu is frequently associated with vegetarianism and veganism, as it is a source of non-animal protein. In India, tofu is used as a low-fat replacement for paneer, providing a similar texture. Awara (also known as wara soya, Nigerian tofu, or Beske), is a food commonly consumed in Northern Nigeria. It's produced by curdling soy milk with a natural agent, then pressing, seasoning, and frying it into cubes. As opposed to an ingredient substitute, the tofu is eaten as the main ingredient, often with vegetables on the side.
== External links == Distillation, An Introduction by Ming Tham, Newcastle University, UK Distillation Theory by Ivar J. Halvorsen and Sigurd Skogestad, Norwegian University of Science and Technology, Norway
=== Dolls === While watching Shinjuuten no Amijima Kaname takes particular notice of the character Koharu, the doll that becomes the ideal of what Kaname thinks women should be (later to be replaced by O-hisa). The conception of womanliness that Koharu inspires in Kaname is what lies at the heart of his Madonna-Harlot conflict, and makes him attracted both to an image of the Virgin Mary and to Hollywood movie stars. He isn’t interested in real women at all, but in idealized forms of them, women who can be appreciated from afar for what they represent not for who they are. Dolls encapsulate this perfectly, being masterfully sculpted, subtle in their beauty, and silently manipulated by men.
Giant, a subsidiary of Cold Storage, is one of the largest players of the retail industry in Singapore as well as in Malaysia, having over 85 branches spread throughout the country. It was founded by the Teng family in 1944. Prices at Giant are significantly cheaper than at Cold Storage.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.